We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.15B
1-Year Est. Return 20.86%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+20.86%
3 Year Est. Return
+68%
5 Year Est. Return
+82.09%
10 Year Est. Return
+321.81%
AUM
$2.11B
AUM Growth
-$10.2M
Cap. Flow
-$12.2M
Cap. Flow %
-0.58%
Top 10 Hldgs %
29.76%
Holding
1,051
New
26
Increased
174
Reduced
289
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 15.81%
2 Financials 10.08%
3 Consumer Discretionary 7.5%
4 Industrials 7.26%
5 Healthcare 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
26
Goldman Sachs
GS
$313B
$18.2M 0.86%
31,765
+1,815
+6% +$1.01M
LLY icon
27
Eli Lilly
LLY
$1T
$18.1M 0.86%
23,495
-5,119
-18% -$4.24M
VCSH icon
28
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$17.4M 0.83%
223,623
-8,970
-4% -$704K
AVGO icon
29
Broadcom
AVGO
$1.96T
$17.2M 0.82%
74,330
+7,672
+12% +$1.42M
MRK icon
30
Merck
MRK
$315B
$16.5M 0.78%
164,700
-13,914
-8% -$1.43M
COST icon
31
Costco
COST
$418B
$16M 0.76%
17,429
-1,919
-10% -$1.78M
ADBE icon
32
Adobe
ADBE
$100B
$15.6M 0.74%
34,970
-1,146
-3% -$567K
SHY icon
33
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$15.1M 0.72%
184,124
+66,292
+56% +$5.45M
IWD icon
34
iShares Russell 1000 Value ETF
IWD
$83B
$14.6M 0.69%
79,060
+10,379
+15% +$1.99M
VGIT icon
35
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
$14.5M 0.69%
250,808
-267,006
-52% -$15.7M
XLK icon
36
State Street Technology Select Sector SPDR ETF
XLK
$122B
$14.4M 0.68%
124,066
-222
-0.2% -$25.8K
JNJ icon
37
Johnson & Johnson
JNJ
$607B
$14.2M 0.67%
97,990
-9,563
-9% -$1.48M
EFX icon
38
Equifax
EFX
$20.6B
$13.8M 0.66%
54,258
-100
-0.2% -$26.8K
VGSH icon
39
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$13.8M 0.65%
237,044
-15,219
-6% -$888K
SYK icon
40
Stryker
SYK
$128B
$13.4M 0.64%
37,207
-124
-0.3% -$45.9K
CPRT icon
41
Copart
CPRT
$26.9B
$13.4M 0.64%
233,628
-2,620
-1% -$149K
MA icon
42
Mastercard
MA
$501B
$13.2M 0.63%
25,045
-137
-0.5% -$70.9K
MAR icon
43
Marriott International
MAR
$89.3B
$13.1M 0.62%
47,054
-804
-2% -$221K
ABBV icon
44
AbbVie
ABBV
$430B
$12.8M 0.61%
72,092
-1,943
-3% -$357K
PEP icon
45
PepsiCo
PEP
$189B
$12.7M 0.6%
82,622
-2,407
-3% -$394K
PG icon
46
Procter & Gamble
PG
$341B
$12.6M 0.6%
75,450
-529
-0.7% -$90.1K
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.11T
$12.6M 0.6%
27,773
+348
+1% +$161K
PH icon
48
Parker-Hannifin
PH
$125B
$11.9M 0.56%
18,637
-494
-3% -$327K
ABT icon
49
Abbott
ABT
$183B
$11.6M 0.55%
102,643
-1,944
-2% -$225K
KRE icon
50
State Street SPDR S&P Regional Banking ETF
KRE
$4.74B
$11M 0.52%
181,685
-1,235
-0.7% -$76.6K

Similar funds

Montag & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Montag & Associates held 1,051 positions worth $2.11B, down 0.48% from $2.12B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Montag & Associates's Q4 2024 filing shows 26 new, 174 increased, 289 reduced and 58 closed positions. Its largest new stake was Vanguard Morningstar Mega Cap ETF: 22,960 shares worth $4.88M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $15.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Montag & Associates's largest Q4 2024 buy was Vanguard Morningstar Mega Cap ETF: 22,960 shares worth $4.88M.
  • Montag & Associates added most to iShares Core S&P Small-Cap ETF in Q4 2024, an estimated $12.7M increase.
  • Montag & Associates's biggest Q4 2024 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $15.7M.
  • Montag & Associates fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $2.99M.
  • Montag & Associates's ten largest holdings make up 30% of its $2.11B portfolio in Q4 2024.
  • Montag & Associates opened 26 new positions and closed 58 in Q4 2024.
  • Montag & Associates's portfolio value fell 0.48% quarter-over-quarter to $2.11B.

Based on Montag & Associates's 13F filing for Q4 2024, filed 30 Jan 2025.